Copyright: ©Author(s) 2026.
World J Gastroenterol. Oct 7, 2026; 32(37): 120860
Published online Oct 7, 2026. doi: 10.3748/wjg.120860
Published online Oct 7, 2026. doi: 10.3748/wjg.120860
Table 1 Comparison of study participants’ variables at baseline and final follow-up
| Variables | Patient 1 | Patient 2 | ||
| Base line | Final follow-up | Base line | Final follow-up | |
| Virus quantitative | HBV DNA 1.5 × 105 IU/mL | Negative | HCV RNA 5 × 104 IU/mL | Negative |
| Ascites | Small amount | None | Small amount | None |
| Hepatic hydrothorax | None | None | Small amount in both sides | None |
| Child-Pugh score | 7 | 5 | 8 | 5 |
| Size of the spleen | 5.6 cm × 16.6 cm | 3.3 cm × 12.7 cm | 5.0 cm × 14.4 cm | 4.0 cm × 10.7 cm |
| Esophageal and gastric varices | Severe | None | Severe | None |
| PPG | 30 mmHg | 5 mmHg | 26 mmHg | 6 mmHg |
- Citation: Tie J, Yuan XL, Niu J, Xu J, Shi YQ. Transjugular intrahepatic portosystemic shunt combined with viral suppression reverses decompensated cirrhosis: Two case reports. World J Gastroenterol 2026; 32(37): 120860
- URL: https://www.wjgnet.com/1007-9327/full/v32/i37/120860.htm
- DOI: https://dx.doi.org/10.3748/wjg.120860